Prognostic value of liver stiffness measurement and contrast-enhanced ultrasound in chronic liver disease: a prospective cohort study
Abdominal Radiology · 21.07.2026
DOI: 10.1007/s00261-026-05678-9 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Abdominal Radiology, online erschienen am 21.07.2026. Verfasst von Shiping Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Suining Traditional Chinese Medicine Hospital, Suining, China. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Chronic liver disease (CLD) has a heterogeneous clinical course, and noninvasive identification of patients at increased risk of liver-related adverse outcomes remains clinically important. Although liver stiffness measurement (LSM) is widely used to assess fibrosis and disease severity, the prognostic value of CEUS findings in CLD remains less well defined. This study evaluated the prognostic value of LSM and CEUS findings, individually and in combination, in patients with CLD. METHODS: A prospective cohort study was conducted involving 258 CLD patients from a tertiary hospital between June 2020 and June 2022. All patients underwent conventional ultrasound, liver elastography (LE), and contrast-enhanced ultrasound (CEUS) examinations, with 3-year follow-up to observe adverse events including hepatic decompensation and hepatocellular carcinoma occurrence. Collinearity assessment and events per variable principle were applied to ensure model stability. Kaplan-Meier method was used for survival analysis, Cox regression for prognostic factor analysis, ROC curves for predictive efficacy evaluation, and subgroup analyses for consistency assessment across different clinical strata. RESULTS: Follow-up was completed in 235 patients (91.08%). During follow-up, 46 liver-related adverse events (19.57%) occurred, including 35 cases of hepatic decompensation, 8 cases of hepatocellular carcinoma, and 3 cases of liver-related deaths. The adverse event group had significantly higher liver stiffness measurement (LSM) values compared to the non-event group (24.68 ± 8.12 kPa vs. 17.02 ± 6.35 kPa, P 0.05). CONCLUSION: Higher LSM values and CEUS abnormalities were independently associated with liver-related adverse outcomes in patients with CLD. Combining LSM and CEUS may improve prognostic stratification; however, prospective external validation is required before routine clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Suining Traditional Chinese Medicine Hospital, Suining, China.
- Suining Maternal and Child Health Care and Family Planning Service Center, Suining, China.
- Preventive Medicine Center, Suining Traditional Chinese Medicine Hospital, Suining, China. chenmingming198108@163.com.
Zitieren
APA
Wu, S., Chen, Q., Qi, J., & Chen, M. (2026). Prognostic value of liver stiffness measurement and contrast-enhanced ultrasound in chronic liver disease: a prospective cohort study. Abdominal Radiology. https://doi.org/10.1007/s00261-026-05678-9
Vancouver
Wu S, Chen Q, Qi J, Chen M. Prognostic value of liver stiffness measurement and contrast-enhanced ultrasound in chronic liver disease: a prospective cohort study. Abdominal Radiology. 2026. doi:10.1007/s00261-026-05678-9
BibTeX
@article{Wu2026,
author = {Wu, Shiping and Chen, Qin and Qi, Junhua and Chen, Mingming},
title = {Prognostic value of liver stiffness measurement and contrast-enhanced ultrasound in chronic liver disease: a prospective cohort study},
journal = {Abdominal Radiology},
year = {2026},
doi = {10.1007/s00261-026-05678-9}
}
EUVIMED